Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

EL AL ISRAEL AIRLINES LTD. (ELAL)

  • Business News
  • March 19, 2026, 06:44 UTC
  • 0
  • 1 comments

Register of shareholders, changes and share capital status

Market reaction Comment Full text

SHAPIR ENGINEERING AND INDUSTRY LTD (SPEN)

  • Business News
  • March 19, 2026, 06:39 UTC
  • 0
  • 1 comments

Appointment of accountant – Somekh Chaikin as of 19.3.26

Market reaction Comment Full text

SHAPIR ENGINEERING AND INDUSTRY LTD (SPEN)

  • Business News
  • March 19, 2026, 06:38 UTC
  • 0
  • 1 comments

Ceased to serve as accountant – Brightman Almagor Zohar & Co., accountants, as of 19.3.26

Market reaction Comment Full text

DUNIEC BROS. LTD. (DUNI)

  • Business News
  • March 19, 2026, 06:30 UTC
  • 0
  • 1 comments

Update regarding the Beit Hakerem (HaArazim) Jerusalem project

Market reaction Comment Full text

AZRIELI GROUP LTD (AZRG)

  • Business News
  • March 19, 2026, 06:23 UTC
  • 0
  • 1 comments

The company’s outstanding liabilities as of 31.12.25, by maturity dates

Market reaction Comment Full text

AZRIELI GROUP LTD (AZRG)

  • Business News
  • March 19, 2026, 06:16 UTC
  • 0
  • 1 comments

Periodic and annual report for 2025

Market reaction Comment Full text

Innate Pharma S.A. (IPHA)

  • Business News
  • March 19, 2026, 06:00 UTC
  • 0
  • 1 comments

Innate Pharma - Innate Pharma Announces Conference Call and Webcast for Full Year 2025 Financial Results

Market reaction Comment Full text

Molecular Partners AG (MOLN)

  • Business News
  • March 19, 2026, 06:00 UTC
  • 0
  • 1 comments

Molecular Partners Presents New Preclinical Data HighlightingRadio-DARPins’ Amenability to Multiple Isotopes

Market reaction Comment Full text

Innate Pharma S.A. (IPHA)

  • Business News
  • March 19, 2026, 06:00 UTC
  • 0
  • 1 comments

Innate Pharma Announces Conference Call and Webcast for Full Year 2025 Financial Results

Market reaction Comment Full text

MOLECULAR PARTNERS AG (MOLN)

  • Business News
  • March 19, 2026, 06:00 UTC
  • 0
  • 1 comments

Molecular Partners Presents New Preclinical Data Highlighting Radio-DARPins’ Amenability to Multiple Isotopes

Market reaction Comment Full text
  • Previous
  • 75
  • 76
  • 77
  • 78
  • 79
  • Next

Search

News categories

  • Technical Exchange News(11334)
  • Event(2785)
  • SEC News(205058)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(133774)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin